MORGAN STANLEY

Holdings History for Prime Medicine, Inc. - COMMON STOCK (PRME)

Symbol: PRME on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$4,059,547	1,169,898	+438,894	+60%	$3.47	Q4 2025
30 Sep 2025	0%	+0%	$4,049,763	731,004	+143,328	+24%	$5.54	Q3 2025
30 Jun 2025	0%	+0%	$1,451,561	587,676	+232,500	+65%	$2.47	Q2 2025
31 Mar 2025	0%	+0%	$706,803	355,176	+43,900		$1.99	Q1 2025
31 Dec 2024	0%	+0%	$908,926	311,276	+10,886		$2.92	Q4 2024
30 Sep 2024		0%	$6	1	0		$6.00 ^*	Q3 2024
30 Sep 2024	0%	+0%	$1,162,509	300,390	+116,425		$3.87	Q3 2024
30 Jun 2024	0%	-0%	$945,586	183,965	-14,500		$5.14	Q2 2024
31 Mar 2024	0%	-0%	$1,389,255	198,465	-13,268	-6.3%	$7.00	Q1 2024
31 Mar 2024		0%	$12	1	0		$12.00 ^*	Q1 2024
31 Dec 2023		0%	$13	1	0		$13.00 ^*	Q4 2023
31 Dec 2023	0%	+0%	$1,875,954	211,733	+168,942	+395%	$8.86	Q4 2023
30 Sep 2023	0%	-0%	$408,227	42,791	-15,138	-26%	$9.54	Q3 2023
30 Jun 2023	0%	+0%	$848,662	57,929	+24,544	+74%	$14.65	Q2 2023
31 Mar 2023	0%	+0%	$410,636	33,385	+12,996	+64%	$12.30	Q1 2023
31 Dec 2022	0%	+0%	$378,827	20,389	+20,389	NEW	$18.58	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.